An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

May 31, 2007

Conditions
BronchoscopyAnesthesia
Interventions
DRUG

AQUAVAN® (fospropofol disodium) Injection

Trial Locations (25)

13790

United Health Scrvices Hosptial, INC, Johnson City

22401

Pulmonary Associates of Fredericksburg, Inc., Fredericksburg

24210

Johnston Memorial Hospital Pulmonary Research, Abingdon

27103

ALL-TRIALS Clinical Research, LLC, Winston-Salem

27834

Brody School of Medicine, Greenville

29303

South Carolina Pharmaceutical Research, Spartanburg

Spartanburg Medical Research, Spartanburg

29406

Lowcountry Lung & Critical Care, PA, Charleston

29425

Medical University of South Carolina, Charleston

29605

Greenville Hospital System, Greenville

30909

Acute Care Consultants Inc., Augusta

32503

Pensacola Research Consultants, Inc., Pensacola

36608

Pulmonary Associates of Mobile, PC, Mobile

42101

Graves-Gilbert Clinic, Bowling Green

45267

University of Cincinnati, The University Hospital, Cincinnati

48503

Hurley Medical Center, Flint

59701

Keith Popovich, MD, PLLC, Butte

59802

International Heart Institue of MT Foundation, Missoula

68198

University of Nebraska Medical Center, Omaha

77555

The University of Texas Medical Branch Division of APICS, Galveston

85032

Precision Trials, Phoenix

90033

USC Health Science Campus (USC University Hospital), Los Angeles

92653

Saddleback Memorial Medical Center, Laguna Hills

04210

Central Maine Pulmonary Associates, Auburn

01201

Berkshire Medical Center, Pittsfield

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00306722 - An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy | Biotech Hunter | Biotech Hunter